Understand this story
Story summary
The English summary is being updated. See the reporting timeline below.
Latest development · Report
Helios Uses Blood Proteins to Assess Disease RiskDevelopments
1 confirmed developments
- Source:Rohan Paul
Reports and discussion timeline
Browse reports and discussion by time. Their evidence levels remain distinct.
Nov 19
Rohan Paul
Helios Uses Blood Proteins to Assess Disease Risk
Y Combinator startup Helios enables needle-free at-home collection of a single drop of blood to measure 1,000+ proteins, compared with the roughly 20 biomarkers checked in a routine physical; an AI agent then interprets the results and identifies which biomarkers indicate an increased risk of disease. Rohan Paul introduced the service with the hook: “An AI agent read all my emails this year, yet still knows nothing about my liver.”
AI Trends